|
|
||||||||
Converting Enzyme or Endocytosed in a Clathrin-Dependent Manner1
,











* Department of Anti-Aging Orthopedic Research,
Department of Orthopedic Surgery, and
Department of Musculoskeletal Reconstruction and Regeneration Surgery, Keio University, School of Medicine, Tokyo, Japan; and
Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, and Departments of Medicine and of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021
CSF-1 is a hemopoietic growth factor, which plays an essential role in macrophage and osteoclast development. Alternative splice variants of CSF-1 are synthesized as soluble or membrane-anchored molecules, although membrane CSF-1 (mCSF-1) can be cleaved from the cell membrane to become soluble CSF-1. The activities involved in this proteolytic processing, also referred to as ectodomain shedding, remain poorly characterized. In the present study, we examined the properties of the mCSF-1 sheddase in cell-based assays. Shedding of mCSF-1 was up-regulated by phorbol ester treatment and was inhibited by the metalloprotease inhibitors GM6001 and tissue inhibitor of metalloproteases 3. Moreover, the stimulated shedding of mCSF-1 was abrogated in fibroblasts lacking the TNF-
converting enzyme (TACE, also known as a disintegrin and metalloprotease 17) and was rescued by expression of wild-type TACE in these cells, strongly suggesting that the stimulated shedding is TACE dependent. Additionally, we observed that mCSF-1 is predominantly localized to intracellular membrane compartments and is efficiently internalized in a clathrin-dependent manner. These results indicate that the local availability of mCSF-1 is actively regulated by ectodomain shedding and endocytosis. This mechanism may have important implications for the development and survival of monocyte lineage cells.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by Nagao Memorial Fund, The Nakatomi Foundation, and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19591765) to K.H.
2 Address correspondence and reprint requests to Dr. Keisuke Horiuchi, Department of Orthopedic Surgery, Keio University, School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail address: horiuchi{at}z3.keio.jp
3 Abbreviations used in this paper: mCSF-1, membrane CSF-1; ADAM, a disintegrin and metalloprotease; ADAMTS, ADAM domain with thrombospondin type I motif; AP, alkaline phosphatase; EGF, epidermal growth factor; ER, endoplasmic reticulum; HA, hemagglutinin; HB, heparin binding; MEF, mouse embryonic fibroblast; MMP, matrix metalloprotease; MT-MMP, membrane-type MMP; PFA, paraformaldehyde; TACE, TNF-
converting enzyme; TIMP, tissue inhibitor of metalloproteases; WGA, wheat germ agglutinin.
This article has been cited by other articles:
![]() |
K. Horiuchi, H. Morioka, H. Takaishi, H. Akiyama, C. P. Blobel, and Y. Toyama Ectodomain Shedding of FLT3 Ligand Is Mediated by TNF-{alpha} Converting Enzyme J. Immunol., June 15, 2009; 182(12): 7408 - 7414. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Horiuchi, T. Kimura, T. Miyamoto, K. Miyamoto, H. Akiyama, H. Takaishi, H. Morioka, T. Nakamura, Y. Okada, C. P. Blobel, et al. Conditional Inactivation of TACE by a Sox9 Promoter Leads to Osteoporosis and Increased Granulopoiesis via Dysregulation of IL-17 and G-CSF J. Immunol., February 15, 2009; 182(4): 2093 - 2101. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |